In addition, overexpression of the PAK2 and pSer20PAK2 proteins in patients was significantly linked to negative clinicopathologic factors, such as advanced tumor stage, positive distant metastasis, increased lymph node metastasis, and deeper tumor depth. The gene discussed is PAK2; the disease is neoplasm.